Vivo Capital

The firm is a 25-year-old global investment firm focused on healthcare with approximately $5.8 billion in AUM, which we have invested in over 290 public and private companies worldwide. Headquartered in Palo Alto, California, with offices in Asia. Our team consists of 50 multi-disciplinary professionals, including, physicians, scientists, entrepreneurs, operating executives, and industry experts. The firm operates as a multi-fund investment platform, covering growth equity, private equity including buyout, venture capital, and public equity. Vivo invests broadly in healthcare across all fund strategies, including biotechnology, pharmaceuticals, medical devices, and healthcare services, with a focus on the largest healthcare markets.

Vivo Capital, established in 1996 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Private Equity, Seed investments across Biotechnology, Health Care, Medical, Venture Capital, Finance, Oil and Gas, Semiconductor, Nanotechnology, Pharmaceutical, Manufacturing. The organization boasts a portfolio of 216 investments, with an average round size of $63.0M and 103 successful exits. Their recent investments include Eiger BioPharmaceuticals, InterWest Partners, CAPNIA, Teknoinvest, Sagent Pharmaceuticals. The highest investment round they participated in was $1286.1B. Among their most notable exits are Eiger BioPharmaceuticals and InterWest Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.